26 sources live Get alerts
HomeBig Tech
Regulation & legal1 min read

Hims & Hers shares fall 10% as FTC sues over data sharing and billing practices

The telehealth company is accused of sharing health data with Meta and Snap and making it difficult to cancel subscriptions
WHY IT MOVED
The lawsuit strikes at the core of the telehealth business model: patient trust in data privacy and frictionless subscription management.
AT PUBLICATION
HIMS26.13▼ -10.88%
META595.84▲ +0.41%
SNAP4.82▲ +1.05%
Measured when this story was written, not live.
HIMS META Regulation & legal Big Tech & AI InstantWhy Newsroom 59 min ago

The case

CNBC reports the Federal Trade Commission has sued Hims & Hers Health, alleging the telehealth company shared user health data with Meta and Snap and engaged in improper billing and subscription cancellation practices. The company's shares fell 10% on the news. The complaint has not been independently confirmed, and Hims & Hers has not commented publicly.

Why it matters

If the FTC's allegations are accurate, they suggest Hims & Hers monetised user health information by sharing it with advertising platforms, a practice that would violate federal health privacy expectations even as the company collected recurring payments. The combination of data-sharing and billing complaints indicates the agency sees a pattern of consumer harm, not an isolated misstep.

Background

This is the second FTC action reported against Hims & Hers in recent weeks, following an earlier lawsuit in late July over similar privacy concerns. The agency has intensified enforcement against digital health companies over the past two years, targeting firms that share sensitive medical information with tech platforms for advertising purposes. Telehealth companies have faced growing scrutiny over subscription practices that make cancellation difficult, a focus area for the FTC under its recent push against so-called dark patterns in online commerce.

What happens next

The company will need to respond to the complaint and may face negotiations over a consent decree, which typically includes financial penalties and mandated changes to data-handling and billing practices. Investors will watch whether the lawsuit triggers broader regulatory review of the telehealth sector's data partnerships with advertising platforms.

SHARE
HOW THIS STORY WAS MADE

Sources

Artificially generated from public sources, explained in our own words, and published as fast as possible. Our team holds editorial responsibility. This is analysis, not investment advice.

More stories

InstantWhy

AT&T and Verizon shares slip on report SpaceX eyes satellite-spectrum acquisitions

Seeking Alpha reports the rocket company is exploring deals and auction participation that would deepen its te
T VZ 2026-07-29 19:24
InstantWhy

Nasdaq futures plunge as chip selloff extends ahead of Fed decision and tech earnings

Technology stock futures fell sharply as semiconductor weakness continued into a week packed with central bank
2026-07-29 19:15
InstantWhy

BMW plans 8,000 job cuts in Germany as automaker deepens cost-cutting drive

OilPrice reports the German carmaker will begin voluntary workforce reductions this fall, with shares down sha
BMW 2026-07-29 19:06

Understand the market in five minutes a day

The free daily brief: what moved, and why it moved.

We store your email to send you the brief, nothing else. No tracking, no selling, unsubscribe in one click. Privacy policy.
We're building up to daily — you'll be among the first to get it.

We use no tracking or advertising cookies. If we ever add analytics, they stay off unless you say yes. Cookie policy